ArticleEClinicalMedicine2023

Change in body weight and risk of hypertension after switching from efavirenz to dolutegravir in adults living with HIV: evidence from routine care in Johannesburg, South Africa.

Alana T Brennan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.